Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

P fizer and Tris Pharma have agreed to pay $41.5m to settle allegations by Texas Attorney General Ken Paxton that they ...

The settlement resolves a 2023 lawsuit that accused the pharmaceutical companies of manipulating quality control tests of a medication used to treat ADHD.

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

MONMOUTH JUNCTION, N.J., April 29, 2021 /PRNewswire/ — Tris Pharma, Inc. (“Tris”), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

MONMOUTH JUNCTION, N.J., July 27, 2022 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that it has ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

Three lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) have been recalled by Tris Pharma, Inc., due to potentially higher concentrations of ibuprofen found in the product. Used as ...

MONMOUTH JUNCTION, N.J. , Aug. 16, 2022 /PRNewswire/ -- Tris Pharma, Inc. (Tris) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that DYANAVEL® XR ...

MONMOUTH JUNCTION, N.J., March 10, 2017 /PRNewswire/ -- Tris Pharma, Inc. (Tris) a specialty pharmaceutical company with a robust portfolio of approved NDAs and late-stage pipeline of innovative ...